Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016-Reference-Cited by-同舟云学术

Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016

Published:2018-12-21 Issue:8 Volume:1 Page:e186371
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Rosenberg Eli S.¹,Rosenthal Elizabeth M.¹,Hall Eric W.²,Barker Laurie³,Hofmeister Megan G.³,Sullivan Patrick S.²,Dietz Patricia⁴,Mermin Jonathan⁴,Ryerson A. Blythe³

Affiliation:

1. Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York, Rensselaer

2. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia

3. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

4. Office of the Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference50 articles.

1. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.;Ditah;J Hepatol,2014

2. Pathogenesis, natural history, treatment, and prevention of hepatitis C.;Liang;Ann Intern Med,2000

3. Natural history of hepatitis C.;Thomas;Clin Liver Dis,2005

4. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.;Micallef;J Viral Hepat,2006

5. Natural history of hepatitis C.;Westbrook;J Hepatol,2014

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peer-Assisted Telemedicine for Hepatitis C (PATHS): Process evaluation results from a State Opioid Response-funded program;Journal of Substance Use and Addiction Treatment;2024-12

2. All-cause and cause-specific mortality risk among men and women with hepatitis C virus infection;PLOS ONE;2024-09-09

3. Trends of primary liver cancer incidence and mortality in the United States: A population-based study over the last four decades;PLOS ONE;2024-09-05

4. Prevalence and associated risk factors of current hepatitis C infection among U.S. general population and injection drug users aged 20–59 years: NHANES 2009–2018;PLOS ONE;2024-08-26

5. Hepatitis C Virus Care Cascade by Race/Ethnicity in a Statewide Correctional Population, 2019–2023;Journal of Racial and Ethnic Health Disparities;2024-07-01